Non-Contact Low-Frequency Ultrasound Vs Standard LaLonde Protocol for Fingertip Injury Wound Healing
Launched by ST. LUKE'S HOSPITAL, PENNSYLVANIA · Feb 5, 2025
Trial Information
Current as of July 01, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different methods of treating fingertip injuries, specifically those involving amputations. The researchers want to find out if a treatment called non-contact low-frequency ultrasound can help wounds heal better compared to a standard method known as the Lalonde protocol. Participants in the study will be randomly assigned to receive either the ultrasound treatment or the standard treatment, and their wound healing will be monitored over a few weeks.
To be eligible for this trial, you must be at least 18 years old and have a recent fingertip amputation without exposed bones or tendons. If you have certain health issues, like vascular disease or infections, or if your injury requires surgery, you may not qualify. If you do participate, you can expect to attend therapy sessions 2-3 times a week, where healthcare professionals will help you with your wound care and measure your progress. This study is currently recruiting participants of all genders, and it aims to provide valuable information on the best ways to help fingertip injuries heal.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Individuals aged 18 years or older with an acute traumatic fingertip amputation without exposed bone or tendons (Allen 1, Tamai level 1; ICD-10 codes S68.5 and S68.6).
- Exclusion Criteria:
- • Patients less than 18 years old,
- • Injuries involving exposed bone
- • Those with diagnosis of vascular disease
- • Individuals with clinical suspicion or diagnosis of infection
- • Unable to comply with prescribed therapy sessions
- • Patients undergoing primary closure or surgical intervention
- • Patients experiencing subsequent trauma following treatment initiation
About St. Luke's Hospital, Pennsylvania
St. Luke's Hospital in Pennsylvania is a leading healthcare institution committed to advancing medical knowledge and patient care through innovative clinical research. As a prominent sponsor of clinical trials, St. Luke's Hospital focuses on a wide range of therapeutic areas, leveraging its state-of-the-art facilities and a team of experienced healthcare professionals to ensure the highest standards of research integrity and participant safety. With a dedication to improving health outcomes, St. Luke's collaborates with pharmaceutical companies, academic institutions, and healthcare organizations to facilitate groundbreaking studies that contribute to the development of new treatments and therapies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bethlehem, Pennsylvania, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported